When did Rapport Therapeutics, Inc. report Q1 2025 earnings?

Rapport Therapeutics, Inc. (RAPP) reported Q1 2025 earnings on May 8, 2025 before market open.

What were Rapport Therapeutics, Inc.'s Q1 2025 revenue and EPS?

Rapport Therapeutics, Inc. reported revenue of - and diluted EPS of $-0.68 for Q1 2025.

Did Rapport Therapeutics, Inc. beat estimates in Q1 2025?

EPS beat the consensus estimate of $-0.77 by $0.09.

Where can I find Rapport Therapeutics, Inc.'s Q1 2025 SEC filings?

You can read the 10-Q periodic report (0000950170-25-066393) directly on SEC EDGAR. The filing index links above go to sec.gov.

Rapport Therapeutics, Inc. RAPP Q1 2025 earnings

Reported May 8, 2025 · Before market open

Revenue-Diluted EPS-$0.68Beat by $0.09

EPS estimate-$0.77

Next report

Aug 6, 2026 (in a month)

Revenue estimate$2.2M

EPS estimate-$0.96

Financials

Q1 2025

Income statement

See full

Revenue-—

Operating income-$27.1M-58.6%

Net income-$24.1M-6.1%

EPS (diluted)-$0.68+93.9%

Balance sheet

See full

Cash & equivalents$57.6M-22.4%

Total debt$7.8M—

Total equity$285.8M+821%

Total assets$302.1M—

Cash flow

See full

Operating cash flow-$20.2M-14.9%

CapEx$291.0K-72.9%

Free cash flow-$20.5M-9.9%

Valuation & ratios

Valuation

as of 03/31/25

See full

Market cap$366.06M—

Enterprise value$316.3M—

Returns & leverage

See full

Debt / equity0×—

Current ratio31×—

Versus estimates

Revenue

Q1 2026$20.0MBeat by $12.5M

Diluted EPS

Q1 2026-$0.42Beat by $0.14 Q4 2025-$0.72Miss by $0.07 Q3 2025-$0.71Beat by $0.06 Q2 2025-$0.75Beat by $0.12

Q1 2025-$0.68Beat by $0.09

Q4 2024-$0.57Beat by $0.05

Ask the moment Rapport Therapeutics, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did Rapport Therapeutics, Inc. report Q1 2025 earnings?: Rapport Therapeutics, Inc. (RAPP) reported Q1 2025 earnings on May 8, 2025 before market open.
What were Rapport Therapeutics, Inc.'s Q1 2025 revenue and EPS?: Rapport Therapeutics, Inc. reported revenue of - and diluted EPS of $-0.68 for Q1 2025.
Did Rapport Therapeutics, Inc. beat estimates in Q1 2025?: EPS beat the consensus estimate of $-0.77 by $0.09.
Where can I find Rapport Therapeutics, Inc.'s Q1 2025 SEC filings?: You can read the 10-Q periodic report (0000950170-25-066393) directly on SEC EDGAR. The filing index links above go to sec.gov.